News

Latest News

Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

Florence (Italy) November 4th, 2021 – The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for...
Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer

Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer

Florence, Italy and Boston, Mass., October 20, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the...
Serie A: the Volpi Rosse Menarini are ready to meet the challenge

Serie A: the Volpi Rosse Menarini are ready to meet the challenge

On 23 October, the first wheelchair basketball team in Tuscany will take part in the Serie A of the National Championship of the FIPIC (Italian Wheelchair Basketball Federation). The athletes will face the Deco Metalferro Amicacci Abruzzo at the Palasport Paolo Valenti in Florence. The details of this success, both sporting and human, were illustrated today during the press conference in Palazzo Vecchio, attended by Cosimo Guccione, Councillor for Sport of the Municipality of Florence. Also present were the team, with new Brazilian coach Ana Cardoso, President Ivano Nuti, and Ennio Troiano, Global Director of Human Re-sources of Menarini, title sponsor of the Volpi Rosse Menarini.

On 23 October, the first wheelchair basketball team in Tuscany will take part in the Serie A of the National Championship of the FIPIC (Italian Wheelchair Basketball Federation). The...
Antibiotic-resistance: Welcome to the "Infection in Focus" website

Antibiotic-resistance: Welcome to the "Infection in Focus" website

Menarini’s disease awareness project starts with endorsement from the Italian Society for Anti-Infective Treatment (Società Italiana di Terapia Antinfettiva Antibatterica-Antivirale-Antifungina, SITA)

The goal of the new "Infection in Focus" website, created by Menarini, is to raise awareness about the value of antibiotics, antimicrobial resistance, and  the importance...
Sporting legends shine on a magical evening at the Menarini Fair Play awards

Sporting legends shine on a magical evening at the Menarini Fair Play awards

The event dedicated to ethics and fair play celebrated its 25th anniversary with a grand finale that welcomed great Italian and international sporting stars

The XXV Menarini International Fair Play awards ceremony saw a genuine outpouring of emotions, with illustrious guests and true legends of Italian and world sport. This 2021 edition was...
International Fair Play Menarini Award: programme and names of the winners of the xxv edition revealed

International Fair Play Menarini Award: programme and names of the winners of the xxv edition revealed

Among the winners, the names of Mihajlovic, Edberg, Bonini and Oliva stand out. The Special Prize dedicated to Paolo Rossi awarded to Tardelli and Muller

Rome, 15th July 2021:  The countdown to the XXV INTERNATIONAL FAIR PLAY MENARINI AWARD has begun and this year’s event was officially announced today at the Press Conference...
The “youth Role model” category of the Fair Play - Menarini Award named in memory of champion footballer Paolo Rossi

The “youth Role model” category of the Fair Play - Menarini Award named in memory of champion footballer Paolo Rossi

AREZZO - The dedication of a prize to the memory of Paolo Rossi will be one of the most moving moments of the XXV International Fair Play – Menarini Award ceremony, planned for...
Press Release June 10th

Press Release June 10th

Content available only in italian language

Menarini Announces New SEL24/MEN1703 Clinical Data from DIAMOND-01 Trial

Menarini Announces New SEL24/MEN1703 Clinical Data from DIAMOND-01 Trial

Pomezia (Italy) June 1st, 2021 – The Menarini Group announced today that additional data have been generated on SEL24/MEN1703, a first-in-class, orally available, dual PIM/FLT3...
Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 – Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of the...
Menarini receives the coveted M&A Award 2021 for the 2020 acquisition of US company Stemline Therapeutics

Menarini receives the coveted M&A Award 2021 for the 2020 acquisition of US company Stemline Therapeutics

Florence, 14th May 2021 - Menarini Group takes home the prestigious  M&A Award 2021 for the “Italy acquires Abroad“ category in recognition of their landmark...
Covid-19: Menarini, new reagent made in Italy for the isolation of viral RNA

Covid-19: Menarini, new reagent made in Italy for the isolation of viral RNA

Florence, 16 April 2021 - Menarini Diagnostics, a company of the Menarini Group, launches Leasy Kit, an innovative reagent, result of its own research and 100% "made in Italy,"...
Menarini Pills of Art Junior project launched, video clips made by the younger generations for children and teenagers

Menarini Pills of Art Junior project launched, video clips made by the younger generations for children and teenagers

Watchword: getting the younger generations talking about art. Following on from the success of the Menarini Pills of Art

INTERNATIONAL FAIR PLAY-MENARINI AWARDS  TO CELEBRATE 25-YEAR ANNIVERSARY

INTERNATIONAL FAIR PLAY-MENARINI AWARDS TO CELEBRATE 25-YEAR ANNIVERSARY

The annual event dedicated to the high-standing values of ethics and fair play will be held in Florence and Castiglion Fiorentino from 30 August to 1 September 2021

Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize ELZONRIS® (Tagraxofusp) in Japan

Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize ELZONRIS® (Tagraxofusp) in Japan

Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize ELZONRIS® (Tagraxofusp) in Japan

Press Release March 5th

Press Release March 5th

Content available only in italian language

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Awareness Day

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Awareness Day

We at Menarini are committed in making a difference in lives of patients. 23rd January 2021 marks the second annual BPDCN Awareness Day (#BPDCNday)

Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)...
Menarini Group awarded the coveted XV Transatlantic Award from American Chamber of Commerce in Italy

Menarini Group awarded the coveted XV Transatlantic Award from American Chamber of Commerce in Italy

Menarini Group awarded the coveted XV Transatlantic Award from American Chamber of Commerce in Italy for the Acquisition of U.S. biopharmaceutical company, Stemline Therapeutics.

1345678910Last

News Archive

 

Company Profile

Download Pdf

youtube Youtube

linkedin Linkedin

Blog Item Image
MENARINI EMPLOYEES
make all the difference, every day.

We are looking for talented people: in order to achieve our mission we need energetic, versatile people with initiative and team-work skills.
Every day we do our jobs with a great sense of commitment, knowing that we are adding more value to the creation of quality drugs.

READ MORE




menarini pills of art

Menarini Pills of Art

Today, with ‘Pills of Art’, Menarini enters the city’s museums to reveal some of the curious facts on the works of the most well-known Renaissance painters. An initiative which confirms the company’s affiliation with art, a close connection which has led them to publish, each year and for more than six decades, an art monograph

Read More
Fair Play Menarini

International Fair Play Menarini Award

International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in the world of sports for the brilliant results attained whilst fully respecting the rules

Read More
Menarini and Farmindustria

Menarini and Farmindustria: together we won’t rest

COVID -19 has brought many changes to our habits and our daily lives, but together we can face - and overcome - our fears. Menarini and Farmindustria, like all of us, won't rest.

Read More
EFPIA

EFPIA - We won’t rest campaign

MENARINI SUPPORTS THE EFPIA CAMPAIGN - WE WON'T REST: Disease never takes a break, so neither do we. We won't rest until people around the world see a brighter tomorrow.

Read More
newsletter

Subscribe to the newsletter

Subscribe to the newsletter to be updated on Menarini news.

Subscribe
Media Contact

Media Contact

To access the service it is necessary to declare to have read the privacy information.

Read More

The Menarini Blog

MENARINI BLOG

menarini for people

Discover our responsibility projects to stand close to people

read more